医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Teleflex to Present for the First Time at the 32nd Annual World Congress of Endourology and Shockwave Lithotripsy

2014年09月02日 PM08:30
このエントリーをはてなブックマークに追加


 

WAYNE, Pa.

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will present for the first time at the 32nd Annual World Congress of Endourology (WCE) and Shockwave Lithotripsy to be held in Taipei, Taiwan on September 3-7, 2014. Teleflex’s presentation will focus on the irrigation system for ureterorenoscopy and a number of other endourological products for customers in the Chinese hospital market.

At WCE, which is the largest and most important annual event for endourologists worldwide, Teleflex will present a number of its Rüsch® brand endourological products, such as the DD ureteral stents and the nephrostomy product range.

In particular, Teleflex will highlight its irrigation system for ureterorenoscopy, which is a unique, comfortable, highly efficient and cost-effective device that complements its Rüsch stone extraction instruments in order to facilitate diagnostics and ureterorenoscopic treatment of calculi in the upper urinary tract.

The very sensitive, hands-free irrigation system provides optimal pressure and flow control during both rigid and flexible ureterorenoscopy. It consists of a robust foot pedal and a sterile single use disposable irrigation set. The simple connection of the irrigation set to the foot pedal and fluid supply provides the urologist with a very sensitive system capable of producing a continuously variable and controllable range of pressures.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care, urology and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 150 countries. Additional information about Teleflex can be obtained from the company’s website at teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management’s current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex and Rüsch are trademarks or registered trademarks of Teleflex Incorporated or its affiliates. © 2014 Teleflex Incorporated. All rights reserved.

CONTACT

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com
www.teleflex.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent